The estimated Net Worth of Jennifer Balliet is at least $768 millier dollars as of 11 December 2020. Mrs. Balliet owns over 15,000 units of Neogenomics stock worth over $652,074 and over the last 10 years she sold NEO stock worth over $116,043. In addition, she makes $0 as Vice President et Chief Culture Officer at Neogenomics.
Jennifer has made over 17 trades of the Neogenomics stock since 2016, according to the Form 4 filled with the SEC. Most recently she exercised 15,000 units of NEO stock worth $120,450 on 11 December 2020.
The largest trade she's ever made was exercising 68,333 units of Neogenomics stock on 9 November 2018 worth over $167,416. On average, Jennifer trades about 13,402 units every 71 days since 2015. As of 11 December 2020 she still owns at least 39,980 units of Neogenomics stock.
You can see the complete history of Mrs. Balliet stock trades at the bottom of the page.
Jennifer M. Balliet serves as Vice President, Chief Culture Officer of the Company. Prior to that, she had served as our Vice President of Human Resources since April 2015. Ms. Balliet joined NeoGenomics in 2008 and has steadily increased her responsibilities; she also previously served as Director of Human Resources. During her time with NeoGenomics, she managed the human resources process as the Company grew from 100 employees to approximately 1,500 employees. As Chief Culture Officer, Ms. Balliet has responsibility for all areas of our Human Resources including recruiting, training, development, compensation, incentive plans and organizational development. Ms. Balliet received her B.S. degree in Psychology and M.S. degree in Business Management from the University of Florida.
Jennifer Balliet is 42, she's been the Vice President et Chief Culture Officer of Neogenomics since 2016. There are 25 older and 1 younger executives at Neogenomics. The oldest executive at Neogenomics Inc. is Raymond Hipp, 77, who is the Independent Director.
Jennifer's mailing address filed with the SEC is 9490 NEOGENOMICS WAY, , FORT MYERS, FL, 33912.
Over the last 12 years, insiders at Neogenomics have traded over $310,374,253 worth of Neogenomics stock and bought 167,456 units worth $1,699,153 . The most active insiders traders include Electric Coge Medical Syste..., Oort Douglas M Van et Steven C Jones. On average, Neogenomics executives and independent directors trade stock every 23 days with the average trade being worth of $2,654,175. The most recent stock trade was executed by Alicia C Olivo on 15 August 2024, trading 1,040 units of NEO stock currently worth $16,692.
neogenomics laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. we work every day to achieve our common purpose of saving lives by improving patient care through communication, accuracy, reliability, and efficiency. our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor fish testing with the largest menu of technical-only services available; 10-color flow cytometry; ihc supported by an extensive antibody library; and over 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out fish, flow cytometry, and/or ihc. neogenomics’ extremely fast test development cycle means we are hig
Neogenomics executives and other stock owners filed with the SEC include: